Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment.
Laffont CM, Gomeni R, Zheng B, Heidbreder C, Fudala PJ, Nasser AF. Laffont CM, et al. Among authors: nasser af. Clin Pharmacokinet. 2014 Jun;53(6):533-43. doi: 10.1007/s40262-014-0132-7. Clin Pharmacokinet. 2014. PMID: 24464285 Clinical Trial.
Liquid chromatography/tandem mass spectrometry method for simultaneous determination of cocaine and its metabolite (-)ecgonine methyl ester in human acidified stabilized plasma samples.
Liu Y, Zheng B, Strafford S, Orugunty R, Sullivan M, Gus J, Heidbreder C, Fudala PJ, Nasser A. Liu Y, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 15;961:77-85. doi: 10.1016/j.jchromb.2014.04.052. Epub 2014 May 4. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 24861875 Clinical Trial.
A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependence.
Nasser AF, Heidbreder C, Gomeni R, Fudala PJ, Zheng B, Greenwald MK. Nasser AF, et al. Clin Pharmacokinet. 2014 Sep;53(9):813-24. doi: 10.1007/s40262-014-0155-0. Clin Pharmacokinet. 2014. PMID: 25015174 Clinical Trial.
Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder.
Laffont CM, Gomeni R, Heidbreder C, Jones JP 3rd, Nasser AF. Laffont CM, et al. Among authors: nasser af. J Clin Pharmacol. 2016 Jul;56(7):806-15. doi: 10.1002/jcph.665. Epub 2016 Mar 11. J Clin Pharmacol. 2016. PMID: 26479717 Clinical Trial.
40 results